Company profile for Biolojic Design

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Powered by AI, Biolojic's technology designs single and multi-specific antibodies precisely targeting predefined epitopes to execute novel biological programs. Focusing on diseases that involve the immune system, Biolojic develops a pipeline of antibodies that are designed to unlock the full potential of we...
Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Powered by AI, Biolojic's technology designs single and multi-specific antibodies precisely targeting predefined epitopes to execute novel biological programs. Focusing on diseases that involve the immune system, Biolojic develops a pipeline of antibodies that are designed to unlock the full potential of well-studied pathways.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Boston, Massachusetts
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/05/27/3088603/0/en/Teva-and-Biolojic-Design-Initiate-IND-enabling-Studies-of-BD9-a-Multibody-Designed-to-Explore-the-Treatment-of-Atopic-Dermatitis-and-Asthma.html

GLOBENEWSWIRE
27 May 2025

https://www.globenewswire.com/news-release/2024/11/21/2985148/0/en/Biolojic-Design-Appoints-Neal-Curran-as-Chief-Business-Officer.html

GLOBENEWSWIRE
21 Nov 2024

https://www.globenewswire.com/news-release/2024/06/03/2892401/0/en/Biolojic-Design-Enters-into-a-Multi-Target-Drug-Discovery-Collaboration-with-Merck-KGaA-Darmstadt-Germany.html

GLOBENEWSWIRE
03 Jun 2024

https://www.globenewswire.com/news-release/2024/04/24/2868445/0/en/Biolojic-Design-Announces-that-Nektar-Therapeutics-Has-Exercised-Its-License-Option-to-Develop-an-AI-Designed-Agonistic-Antibody-Targeting-TNFR2-for-the-Treatment-of-Autoimmune-Dis.html

GLOBENEWSWIRE
24 Apr 2024

https://www.businesswire.com/news/home/20231214673739/en

BUSINESSWIRE
14 Dec 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty